SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

GRAZI, Gian Luca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 3.487
NA - Nord America 3.297
SA - Sud America 1.124
EU - Europa 892
AF - Africa 89
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 3
Totale 8.897
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.162
SG - Singapore 1.758
BR - Brasile 909
HK - Hong Kong 520
CN - Cina 471
VN - Vietnam 366
RU - Federazione Russa 193
IT - Italia 188
ID - Indonesia 162
DE - Germania 134
GB - Regno Unito 107
MX - Messico 82
AR - Argentina 76
UA - Ucraina 50
AT - Austria 46
EC - Ecuador 44
NL - Olanda 40
ZA - Sudafrica 39
BD - Bangladesh 36
FI - Finlandia 36
CO - Colombia 33
IN - India 33
TR - Turchia 32
CA - Canada 24
PY - Paraguay 24
SE - Svezia 24
FR - Francia 21
IQ - Iraq 21
CL - Cile 13
JP - Giappone 12
ES - Italia 10
DO - Repubblica Dominicana 9
KE - Kenya 9
MA - Marocco 9
PK - Pakistan 9
VE - Venezuela 9
AZ - Azerbaigian 8
UZ - Uzbekistan 8
TN - Tunisia 7
IE - Irlanda 6
JM - Giamaica 6
PE - Perù 6
PL - Polonia 6
UY - Uruguay 6
DZ - Algeria 5
JO - Giordania 5
KR - Corea 5
KZ - Kazakistan 5
LT - Lituania 5
BO - Bolivia 4
EG - Egitto 4
IL - Israele 4
SA - Arabia Saudita 4
TW - Taiwan 4
BY - Bielorussia 3
CR - Costa Rica 3
HN - Honduras 3
MO - Macao, regione amministrativa speciale della Cina 3
NG - Nigeria 3
NZ - Nuova Zelanda 3
OM - Oman 3
SN - Senegal 3
AL - Albania 2
AM - Armenia 2
AU - Australia 2
BE - Belgio 2
BG - Bulgaria 2
BH - Bahrain 2
CH - Svizzera 2
CZ - Repubblica Ceca 2
EE - Estonia 2
ET - Etiopia 2
EU - Europa 2
HU - Ungheria 2
IR - Iran 2
KW - Kuwait 2
LB - Libano 2
NP - Nepal 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BW - Botswana 1
CD - Congo 1
DK - Danimarca 1
GA - Gabon 1
GP - Guadalupe 1
GR - Grecia 1
IM - Isola di Man 1
KG - Kirghizistan 1
KN - Saint Kitts e Nevis 1
LU - Lussemburgo 1
LV - Lettonia 1
MD - Moldavia 1
MG - Madagascar 1
MK - Macedonia 1
ML - Mali 1
MN - Mongolia 1
MW - Malawi 1
MY - Malesia 1
Totale 8.887
Salva come PNG Salva come JPEG
Città #
Singapore 802
Santa Clara 708
Hong Kong 520
Ashburn 293
Fairfield 273
Beijing 226
Chandler 165
Ho Chi Minh City 132
Jakarta 130
Woodbridge 103
Houston 96
Hanoi 82
São Paulo 74
Seattle 73
Princeton 72
Wilmington 72
Mexico City 62
Cambridge 58
Moscow 55
Chicago 46
Dallas 45
San Diego 42
Ann Arbor 40
Nuremberg 40
London 36
Los Angeles 34
Helsinki 30
Rio de Janeiro 29
Shanghai 28
Salt Lake City 23
Vienna 22
Jacksonville 21
Rome 20
Belo Horizonte 18
Curitiba 17
Quito 17
Falkenstein 16
Falls Church 16
Guangzhou 16
Haiphong 16
New York 16
Porto Alegre 16
Portsmouth 16
Biên Hòa 15
Brasília 14
Ferrara 14
Baghdad 13
Da Nang 12
Lauterbourg 12
Milan 12
Bologna 11
Guarulhos 11
Guayaquil 11
Medellín 11
Brooklyn 10
Dhaka 10
Fortaleza 10
Hangzhou 10
Asunción 9
Campinas 9
Johannesburg 9
Juiz de Fora 9
Montreal 9
St Petersburg 9
Tokyo 9
Ankara 8
Baku 8
Hải Dương 8
Salvador 8
Tampa 8
Tashkent 8
Xian 8
Buenos Aires 7
Can Tho 7
Duque de Caxias 7
Düsseldorf 7
Hounslow 7
Kilburn 7
Manaus 7
Osasco 7
Ribeirão Preto 7
Bắc Giang 6
Carapicuíba 6
Chennai 6
Frankfurt am Main 6
Lubbock 6
Mountain View 6
Nairobi 6
Norwalk 6
Phủ Lý 6
Redwood City 6
Sorocaba 6
Sterling 6
Stockholm 6
São Bernardo do Campo 6
São José dos Campos 6
Vicenza 6
Amman 5
Bari 5
Cabo Frio 5
Totale 5.085
Salva come PNG Salva come JPEG
Nome #
MiR-199a-3p regulates mTOR and c-Met to influence the doxorubicin sensitivity of human hepatocarcinoma cells 178
MicroRNA-221 targets Bmf in hepatocellular carcinoma and correlates with tumor multifocality 146
MiR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells 144
Early onset aggressive hereditary amyloidosis: report of an Italian family with TTR Arg47 mutation. 119
Tumor Regression Grade After Neoadjuvant Chemoradiation and Surgery for Low Rectal Cancer Evaluated by Multiple Correspondence Analysis: Ten Years as Minimum Follow-up 107
A Pan-Cancer Analysis of Enhancer Expression in Nearly 9000 Patient Samples 103
The Immune Landscape of Cancer 103
A Comprehensive Pan-Cancer Molecular Study of Gynecologic and Breast Cancers 93
Adjuvant, adoptive immunotherapy with tumor infiltrating lymphocytes plus interleukin-2 after radical hepatic resection for colorectal liver metastases: 5-year analysis 92
A case report of giant hepatic hemangioma spontaneous regression in adult, non-cirrhotic patient and literature review 89
The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma 88
An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics 85
Oncogenic Signaling Pathways in The Cancer Genome Atlas 83
Comprehensive Characterization of Cancer Driver Genes and Mutations 80
Performance of comprehensive complication index and clavien‐dindo complication scoring system in liver surgery for hepatocellular carcinoma 76
Perspective on Oncogenic Processes at the End of the Beginning of Cancer Genomics 74
A Pan-Cancer Analysis Reveals High-Frequency Genetic Alterations in Mediators of Signaling by the TGF-β Superfamily 73
The Impact of Hospital Volume on Failure to Rescue after Liver Resection for Hepatocellular Carcinoma: Analysis from the HE.RC.O.LE.S. Italian Registry 73
Hepatocellular carcinoma surgical and oncological trends in a national multicentric population: the HERCOLES experience 73
Comprehensive Molecular Characterization of the Hippo Signaling Pathway in Cancer 72
Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas 70
Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer 70
Anti-HBs re-seroconversion after liver transplantation in a patient with past HBV infection receiving a HBsAg positive graft 70
Metformin exerts anti-cancerogenic effects and reverses epithelial-to-mesenchymal transition trait in primary human intrahepatic cholangiocarcinoma cells 70
Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients 69
ALPPS for primary and secondary liver tumors 68
Cholangiocarcinoma landscape in Europe: diagnostic, prognostic and therapeutic insights from the ENSCCA Registry 68
A Novel Nomogram to Predict the Prognosis of Patients Undergoing Liver Resection for Neuroendocrine Liver Metastasis: an Analysis of the Italian Neuroendocrine Liver Metastasis Database 67
Renewed considerations on the utility (or the futility) of hepatic resections for breast cancer liver metastases 66
Multiple hepatocellular carcinoma: Long-term outcomes following resection beyond actual guidelines. An Italian multicentric retrospective study 66
Italian Clinical Practice Guidelines on Cholangiocarcinoma – Part I: Classification, diagnosis and staging 64
Primary leiomyoma of the liver in an immunocompetent patient 63
DCLK1, a putative novel stem cell marker in human cholangiocarcinoma 63
A new priority policy for patients with hepatocellular carcinoma awaiting liver transplantation within the model for end-stage liver disease system 62
Impact of model for end-stage liver disease (MELD) score on prognosis after hepatectomy for hepatocellular carcinoma on cirrhosis 61
Curative versus palliative treatments for recurrent hepatocellular carcinoma: a multicentric weighted comparison 61
Scalable Open Science Approach for Mutation Calling of Tumor Exomes Using Multiple Genomic Pipelines 60
Pathogenic Germline Variants in 10,389 Adult Cancers 60
Criteria for diagnosing benign portal vein thrombosis in the assessment of patients with cirrhosis and hepatocellular carcinoma for liver transplantation 60
Wnt3a/b-Catenin signaling conditions differentiation of partially exhausted T-effector cells in human cancers 59
Forcing ATGL expression in hepatocarcinoma cells imposes glycolytic rewiring through PPAR-α/p300-mediated acetylation of p53 59
Partial necrosis on hepatocellular carcinoma nodules facilitates tumor recurrence after liver transplantation 58
Laboratory test variability and Model for End-Stage Liver Disease score calculation: effect on liver allocation and proposal for adjustment 58
Diffusion, outcomes and implementation of minimally invasive liver surgery: a snapshot from the I Go MILS (Italian Group of Minimally Invasive Liver Surgery) Registry 58
Liver resection for hepatocellular carcinoma on cirrhosis: a univariate and multivariate analysis of risk factors for intrahepatic recurrence 57
Genomic and Functional Approaches to Understanding Cancer Aneuploidy 57
Expression of connective tissue growth factor is a prognostic marker for patients with intrahepatic cholangiocarcinoma 57
The actin modulator hMENA regulates GAS6-AXL axis and pro-tumor cancer/stromal cell cooperation 57
Benchmarking postoperative outcomes after open liver surgery for cirrhotic patients with hepatocellular carcinoma in a national cohort 56
Association of polygenic risk score and bacterial toxins at screening colonoscopy with colorectal cancer progression: A multicenter case-control study 56
lncRNA Epigenetic Landscape Analysis Identifies EPIC1 as an Oncogenic lncRNA that Interacts with MYC and Promotes Cell-Cycle Progression in Cancer 55
Italian Clinical Practice Guidelines on Cholangiocarcinoma - Part II: Treatment 55
Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation 54
Comparison of recurrence of hepatocellular carcinoma after resection in patients with cirrhosis to its occurrence in a surveilled cirrhotic population 54
Molecular Aging of Human Liver: An Epigenetic/Transcriptomic Signature 54
Down-staging of hepatocellular carcinoma prior to liver transplantation: the power of selection 54
Key components of a hepatobiliary surgery curriculum for general surgery residents: results of the FULCRUM International Delphi consensus 53
Analysis of factors affecting recurrence of hepatocellular carcinoma after liver transplantation with a special focus on inflammation markers 53
Effect of ischemic preconditioning in whole liver transplantation from deceased donors. A pilot study 53
Genetically driven CD39 expression shapes human tumor-infiltrating CD8+ T-cell functions 52
Perspectives from Italy during the COVID-19 pandemic: nationwide survey-based focus on minimally invasive HPB surgery 52
FGFR2 fusion proteins drive oncogenic transformation of mouse liver organoids towards cholangiocarcinoma 52
Harm and benefits of primary liver resection and salvage transplantation for hepatocellular carcinoma 51
Outcome of Right Hepatectomies in Patients Older Than 70 Years 51
Is it time to develop a robotic difficulty score system? 51
Impact of a goal-directed fluid therapy on length of hospital stay and costs of hepatobiliarypancreatic surgery: A prospective observational study 51
Multicentre evaluation of case volume in minimally invasive hepatectomy 50
Liver allocation for hepatocellular carcinoma: a European Center policy in the pre-MELD era 50
The pattern of hMENA isoforms is regulated by TGF-β1 in pancreatic cancer and may predict patient outcome 50
Adjuvant systemic chemotherapy after putative curative resection of colorectal liver and lung metastases 50
Blood transfusions and steatohepatitis are independent risk factors for complications following liver resection for colorectal cancer liver metastases 50
Pan-cancer Alterations of the MYC Oncogene and Its Proximal Network across the Cancer Genome Atlas 50
The FXR agonist obeticholic acid inhibits the cancerogenic potential of human cholangiocarcinoma 50
Laparoscopic liver resection of hepatocellular carcinoma located in unfavorable segments: a propensity score-matched analysis from the I Go MILS (Italian Group of Minimally Invasive Liver Surgery) Registry 50
Robotic Liver Resections: Application of Difficulty Score Systems to an Initial Experience. Is a Specific Robotic Difficulty Score Necessary? 50
The peculiar aging of human liver: A geroscience perspective within transplant context 50
Associated benign liver tumors in idiopathic granulomatous hepatitis: a case report 49
Comparison between the fifth and sixth editions of the AJCC/UICC TNM staging systems for hepatocellular carcinoma: multicentric study on 393 cirrhotic resected patients 49
Identification of miR-31-5p, miR-141-3p, miR-200c-3p, and GLT1 as human liver aging markers sensitive to donor-recipient age-mismatch in transplants 49
Evolution of pancreatectomy with en bloc venous resection for pancreatic cancer in Italy. Retrospective cohort study on 425 cases in 10 pancreatic referral units 49
Aberrant Notch3 and Notch4 expression in human hepatocellular carcinoma 48
Down-staging of hepatocellular carcinoma before liver transplantation: should we change our clinical practice? 48
Coping strategies in intestinal transplantation 47
A room for the alpps procedure in patients with HCC 47
Changes in the surgical approach to hilar cholangiocarcinoma during an 18-year period in a Western single center 47
Multicohort and cross-platform validation of a prognostic Wnt signature in colorectal cancer 47
Hepatectomy Versus Sorafenib in Advanced Non-Metastatic Hepatocellular Carcinoma: A Real-Life Multicentric Weighted Comparison 47
A bioluminescent mouse model of proliferation to highlight early stages of pancreatic cancer: A suitable tool for preclinical studies 46
Epigenome-wide association study in hepatocellular carcinoma: Identification of stochastic epigenetic mutations through an innovative statistical approach 46
Daclizumab and alemtuzumab as induction agents in adult intestinal and multivisceral transplantation: rejection and infection rates in 40 recipients during the early postoperative period 45
Liver and partial atrium transplantation for chronic Budd-Chiari syndrome 45
Laparoscopic Liver Surgery: What Are the Advantages in Patients with Cirrhosis and Portal Hypertension? Systematic Review and Meta-Analysis with Personal Experience 45
Liver transplantation for hepatocellular carcinoma: further considerations on selection criteria 44
12-month follow-up analysis of a multicenter, randomized, prospective trial in de novo liver transplant recipients (LIS2T) comparing cyclosporine microemulsion (C2 monitoring) and tacrolimus 44
Efficacy of MELD score in predicting survival after liver retransplantation 44
Double-blind comparison of hepatitis C histological recurrence Rate in HCV+ Liver transplant recipients given basiliximab + steroids or basiliximab + placebo, in addition to cyclosporine and azathioprine 44
Absence of neuroinvasive disease in a liver transplant recipient who acquired West Nile virus (WNV) infection from the organ donor and who received WNV antibodies prophylactically 43
Histological recurrent hepatitis C after liver transplantation: Outcome and role of retransplantation 43
A revised consideration on the use of very aged donors for liver transplantation 43
The Impact of Postoperative Ascites on Survival After Surgery for Hepatocellular Carcinoma: a National Study 43
Totale 6.268
Salva come PNG Salva come JPEG
Categoria #
all - tutte 104.523
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 104.523
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021345 0 0 0 0 0 5 0 65 109 31 110 25
2021/2022629 15 114 7 6 13 11 127 73 41 22 58 142
2022/2023797 75 45 8 50 46 397 9 41 64 4 35 23
2023/2024498 38 79 38 22 24 18 14 19 19 8 30 189
2024/20253.195 115 49 326 3 376 392 58 129 402 836 238 271
2025/20263.649 467 344 852 1.009 930 47 0 0 0 0 0 0
Totale 9.414